Other AD-related biomarkers including CSF Aβ-42, Aβ-42/P-tau ratio, and Aβ-42/T-tau ratio distinguished the PD-R from the PD-I and PD-M subtypes. This evidence concerns the gene POLA1 and Alzheimer disease.